19 May 2013
Keywords: s-p, boceprevir, sees, svr, weeks, drug, major
Article | 05 May 2008
US drug major Schering-Plough presented encouraging results from a planned interim analysis of an ongoing Phase II study of boceprevir, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2008
28 April 2008
17 May 2013
© 2013 thepharmaletter.com